Literature DB >> 3169275

Anastomotic arteriovenous fistulae--are they worth it?

B R Gwynn1, C P Shearman, M H Simms.   

Abstract

An adjuvant distal arteriovenous fistula (ADAVF) has been claimed to increase arterial bypass graft flow and patency when run-off is poor but others have suggested that a patent fistula does not improve in distal limb perfusion. In 10 dogs, hind limbs were rendered ischaemic by proximal arterial ligations and then revascularised with vein grafts. In each dog an ADAVF was constructed on the left graft while the right was used as a control. Flow and pressure were measured in each graft and distal artery and the effect of temporary occlusion and release of the fistula noted. These measurements were repeated at re-operation 3 months later. Mean flow through control grafts was 83 +/- 8.57 (S.E.M.) ml/min, increasing to 146 +/- 22.89 (S.E.M.) ml/min with papaverine (P less than 0.001, Student's t test), and was unchanged at 3 months. Mean flow in grafts with a distal A-V fistula was 250 +/- 41.68 (S.E.M.) ml/min with no change after papaverine, and an increase to 730 +/- 110.5 (S.E.M.) ml/min at 3 months (P less than 0.001, Student's t test). However, arterial flow distal to the fistula was invariably retrograde at initial operation (20 +/- 3.0 S.E.M. ml/min), and this retrograde flow increased to 180 +/- 33.2 (S.E.M.) ml/min at 3 months (P less than 0.001, Student's t test). Distal arterial pressure at initial operation fell from 88.8 +/- 3.35 (S.E.M.) mmHg to 10.8 +/- 1.01 (S.E.M.) mmHg with the fistula open. We conclude that in this animal model an adjuvant distal arteriovenous fistula may improve bypass graft flow, but is unlikely to benefit distal limb perfusion.

Entities:  

Mesh:

Year:  1988        PMID: 3169275     DOI: 10.1016/s0950-821x(88)80051-3

Source DB:  PubMed          Journal:  Eur J Vasc Surg        ISSN: 0950-821X


  1 in total

1.  Hemodynamics of revascularization of the corpora cavernosa in an animal model. A preliminary report.

Authors:  A Floth; J S Paick; J K Suh; T F Lue
Journal:  Urol Res       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.